A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer-Reference-Cited by-同舟云学术

A comparison of the CARG tool, the VES-13, and oncologist judgment in predicting grade 3+ toxicities in men undergoing chemotherapy for metastatic prostate cancer

Published:2017-01 Issue:1 Volume:8 Page:31-36
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Alibhai Shabbir M.H.,Aziz Salman,Manokumar Tharsika,Timilshina Narhari,Breunis Henriette

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference26 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

2. Treatment of mCRPC in the AR-axis-targeted therapy-resistant state;Chi;Ann Oncol,2015

3. Chemotherapy-based treatment for castration-resistant prostate cancer;Seruga;J Clin Oncol,2011

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

5. Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial;Horgan;J Geriatr Oncol,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Frailty on the Toxic Reaction of Chemotherapy in Patients With Cervical Cancer;Cancer Nursing;2024-09-04

2. Frailty and Cancer Prognosis;Current Oncology Reports;2024-06-12

3. Prostate Cancer;Geriatric Medicine;2024

4. Chemotherapy-Related Toxic Effects and Quality of Life and Physical Functioning in Older Patients;JAMA Network Open;2023-10-23

5. External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort;The Oncologist;2023-04-07